EPISODE · Apr 25, 2018 · 11 MIN
PROs in regulatory decision making
from Listen to The Lancet Oncology · host The Lancet
Paul Kluetz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision making.
Embed this episode
NOW PLAYING
PROs in regulatory decision making
0:00
11:33
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Oncology?
This episode is 11 minutes long.
When was this Listen to The Lancet Oncology episode published?
This episode was published on April 25, 2018.
Can I download this Listen to The Lancet Oncology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!